{
     "PMID": "19123962",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20090818",
     "LR": "20161020",
     "IS": "1469-5111 (Electronic) 1461-1457 (Linking)",
     "VI": "12",
     "IP": "6",
     "DP": "2009 Jul",
     "TI": "Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice.",
     "PG": "793-803",
     "LID": "10.1017/S1461145708009760 [doi]",
     "AB": "We recently found that the response of DBA/2 mice to SSRIs in the forced swim test (FST) was impaired and they also had a smaller basal and citalopram-stimulated increase in brain extracellular serotonin (5-HT) than 'responder' strains. We employed intracerebral microdialysis, FST and selective antagonists of 5-HT1A and 5-HT2C receptors to investigate whether enhancing the increase in extracellular 5-HT reinstated the anti-immobility effect of citalopram in the FST. WAY 100635 (0.3 mg/kg s.c.) or SB 242084 (1 mg/kg s.c.), respectively a selective 5-HT1A and 5-HT2C receptor antagonist, raised the effect of citalopram (5 mg/kg) on extracellular 5-HT in the medial prefrontal cortex of DBA/2N mice (citalopram alone 5.2+/-0.3 fmol/20 microl, WAY 100635+citalopram 9.9+/-2.1 fmol/20 microl, SB 242084+ citalopram 7.6+/-1.0 fmol/20 microl) to the level reached in 'responder' mice given citalopram alone. The 5-HT receptor antagonists had no effect on the citalopram-induced increase in extracellular 5-HT in the dorsal hippocampus. The combination of citalopram with WAY 100635 or SB 242084 significantly reduced immobility time in DBA/2N mice that otherwise did not respond to either drug singly. Brain levels of citalopram in mice given citalopram alone or with 5-HT antagonists did not significantly differ. The results confirm that impaired 5-HT transmission accounts for the lack of effect of citalopram in the FST and suggest that enhancing the effect of SSRIs on extracellular 5-HT, through selective blockade of 5-HT1A and 5-HT2C receptors, could be a useful strategy to restore the response in treatment-resistant depression.",
     "FAU": [
          "Calcagno, Eleonora",
          "Guzzetti, Sara",
          "Canetta, Alessandro",
          "Fracasso, Claudia",
          "Caccia, Silvio",
          "Cervo, Luigi",
          "Invernizzi, Roberto W"
     ],
     "AU": [
          "Calcagno E",
          "Guzzetti S",
          "Canetta A",
          "Fracasso C",
          "Caccia S",
          "Cervo L",
          "Invernizzi RW"
     ],
     "AD": "Laboratory of Neurochemistry and Behaviour, Istituto di Ricerche Farmacologiche 'Mario Negri', Via La Masa 19, 20156 Milan, Italy.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20090105",
     "PL": "England",
     "TA": "Int J Neuropsychopharmacol",
     "JT": "The international journal of neuropsychopharmacology",
     "JID": "9815893",
     "RN": [
          "0 (6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline)",
          "0 (Aminopyridines)",
          "0 (Antidepressive Agents)",
          "0 (Indoles)",
          "0 (Piperazines)",
          "0 (Pyridines)",
          "0 (Serotonin 5-HT1 Receptor Antagonists)",
          "0 (Serotonin 5-HT2 Receptor Antagonists)",
          "0 (Serotonin Antagonists)",
          "0DHU5B8D6V (Citalopram)",
          "333DO1RDJY (Serotonin)",
          "71IH826FEG",
          "(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxa",
          "mide)"
     ],
     "SB": "IM",
     "MH": [
          "Aminopyridines/pharmacology",
          "Analysis of Variance",
          "Animals",
          "Antidepressive Agents/pharmacokinetics",
          "Cerebral Cortex/*cytology/drug effects",
          "Citalopram/pharmacokinetics",
          "Drug Interactions",
          "Exploratory Behavior/drug effects",
          "Extracellular Fluid/drug effects/*metabolism",
          "Indoles/pharmacology",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Inbred DBA",
          "Microdialysis/methods",
          "Piperazines/pharmacology",
          "Pyridines/pharmacology",
          "Serotonin/*metabolism",
          "*Serotonin 5-HT1 Receptor Antagonists",
          "*Serotonin 5-HT2 Receptor Antagonists",
          "Serotonin Antagonists/pharmacology"
     ],
     "EDAT": "2009/01/07 09:00",
     "MHDA": "2009/08/19 09:00",
     "CRDT": [
          "2009/01/07 09:00"
     ],
     "PHST": [
          "2009/01/07 09:00 [entrez]",
          "2009/01/07 09:00 [pubmed]",
          "2009/08/19 09:00 [medline]"
     ],
     "AID": [
          "S1461145708009760 [pii]",
          "10.1017/S1461145708009760 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Int J Neuropsychopharmacol. 2009 Jul;12(6):793-803. doi: 10.1017/S1461145708009760. Epub 2009 Jan 5.",
     "term": "hippocampus"
}